Applications of Cardiac Computed Tomography in the Cardio-Oncology Population

Michael E. Layoun, Eric H. Yang, Joerg Herrmann, Cezar A. Iliescu, Juan C. Lopez-Mattei, Kostas Marmagkiolis, Matthew J. Budoff, Maros Ferencik

    Research output: Contribution to journalReview article

    Abstract

    The increased risk for cardiovascular events in aging cancer survivors and those undergoing certain chemotherapeutic treatments has raised concern for more rigorous screening and surveillance methods above that of the general population. At this time, there are limited guidelines for how to best manage this vulnerable cohort. Questions regarding timing of screening, choice of imaging modality and risk reduction strategies—especially in those patients with known atherosclerotic disease—remain to be elucidated. Over a decade of case series, retrospective studies and clinical trials have shed light on the evolving role of cardiac computed tomography (CT) in this population, of which there is a relative paucity of data regarding its potential utility in the specific cardio-oncology population. Focusing on ability of cardiac CT to evaluate multiple cardiac and vascular structures, provide diagnostic and prognostic information, as well as assist interventional and surgical colleagues in surgical/percutaneous valve replacement and revascularization strategies is the premise for this review.

    Original languageEnglish (US)
    Article number47
    JournalCurrent treatment options in oncology
    Volume20
    Issue number6
    DOIs
    StatePublished - Jun 1 2019

    Fingerprint

    Tomography
    Population
    Aptitude
    Risk Reduction Behavior
    Surgical Instruments
    Blood Vessels
    Survivors
    Retrospective Studies
    Clinical Trials
    Guidelines
    Neoplasms
    Therapeutics

    Keywords

    • Cardiac computed tomography angiography
    • Cardiotoxicity
    • Coronary artery calcium score
    • Radiation-induced valvulopathy
    • Vasculotoxicity

    ASJC Scopus subject areas

    • Oncology
    • Pharmacology (medical)

    Cite this

    Layoun, M. E., Yang, E. H., Herrmann, J., Iliescu, C. A., Lopez-Mattei, J. C., Marmagkiolis, K., ... Ferencik, M. (2019). Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. Current treatment options in oncology, 20(6), [47]. https://doi.org/10.1007/s11864-019-0645-2

    Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. / Layoun, Michael E.; Yang, Eric H.; Herrmann, Joerg; Iliescu, Cezar A.; Lopez-Mattei, Juan C.; Marmagkiolis, Kostas; Budoff, Matthew J.; Ferencik, Maros.

    In: Current treatment options in oncology, Vol. 20, No. 6, 47, 01.06.2019.

    Research output: Contribution to journalReview article

    Layoun, ME, Yang, EH, Herrmann, J, Iliescu, CA, Lopez-Mattei, JC, Marmagkiolis, K, Budoff, MJ & Ferencik, M 2019, 'Applications of Cardiac Computed Tomography in the Cardio-Oncology Population', Current treatment options in oncology, vol. 20, no. 6, 47. https://doi.org/10.1007/s11864-019-0645-2
    Layoun ME, Yang EH, Herrmann J, Iliescu CA, Lopez-Mattei JC, Marmagkiolis K et al. Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. Current treatment options in oncology. 2019 Jun 1;20(6). 47. https://doi.org/10.1007/s11864-019-0645-2
    Layoun, Michael E. ; Yang, Eric H. ; Herrmann, Joerg ; Iliescu, Cezar A. ; Lopez-Mattei, Juan C. ; Marmagkiolis, Kostas ; Budoff, Matthew J. ; Ferencik, Maros. / Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. In: Current treatment options in oncology. 2019 ; Vol. 20, No. 6.
    @article{11aec7a0788147dda6f850b634ad718b,
    title = "Applications of Cardiac Computed Tomography in the Cardio-Oncology Population",
    abstract = "The increased risk for cardiovascular events in aging cancer survivors and those undergoing certain chemotherapeutic treatments has raised concern for more rigorous screening and surveillance methods above that of the general population. At this time, there are limited guidelines for how to best manage this vulnerable cohort. Questions regarding timing of screening, choice of imaging modality and risk reduction strategies—especially in those patients with known atherosclerotic disease—remain to be elucidated. Over a decade of case series, retrospective studies and clinical trials have shed light on the evolving role of cardiac computed tomography (CT) in this population, of which there is a relative paucity of data regarding its potential utility in the specific cardio-oncology population. Focusing on ability of cardiac CT to evaluate multiple cardiac and vascular structures, provide diagnostic and prognostic information, as well as assist interventional and surgical colleagues in surgical/percutaneous valve replacement and revascularization strategies is the premise for this review.",
    keywords = "Cardiac computed tomography angiography, Cardiotoxicity, Coronary artery calcium score, Radiation-induced valvulopathy, Vasculotoxicity",
    author = "Layoun, {Michael E.} and Yang, {Eric H.} and Joerg Herrmann and Iliescu, {Cezar A.} and Lopez-Mattei, {Juan C.} and Kostas Marmagkiolis and Budoff, {Matthew J.} and Maros Ferencik",
    year = "2019",
    month = "6",
    day = "1",
    doi = "10.1007/s11864-019-0645-2",
    language = "English (US)",
    volume = "20",
    journal = "Current Treatment Options in Oncology",
    issn = "1527-2729",
    publisher = "Springer New York",
    number = "6",

    }

    TY - JOUR

    T1 - Applications of Cardiac Computed Tomography in the Cardio-Oncology Population

    AU - Layoun, Michael E.

    AU - Yang, Eric H.

    AU - Herrmann, Joerg

    AU - Iliescu, Cezar A.

    AU - Lopez-Mattei, Juan C.

    AU - Marmagkiolis, Kostas

    AU - Budoff, Matthew J.

    AU - Ferencik, Maros

    PY - 2019/6/1

    Y1 - 2019/6/1

    N2 - The increased risk for cardiovascular events in aging cancer survivors and those undergoing certain chemotherapeutic treatments has raised concern for more rigorous screening and surveillance methods above that of the general population. At this time, there are limited guidelines for how to best manage this vulnerable cohort. Questions regarding timing of screening, choice of imaging modality and risk reduction strategies—especially in those patients with known atherosclerotic disease—remain to be elucidated. Over a decade of case series, retrospective studies and clinical trials have shed light on the evolving role of cardiac computed tomography (CT) in this population, of which there is a relative paucity of data regarding its potential utility in the specific cardio-oncology population. Focusing on ability of cardiac CT to evaluate multiple cardiac and vascular structures, provide diagnostic and prognostic information, as well as assist interventional and surgical colleagues in surgical/percutaneous valve replacement and revascularization strategies is the premise for this review.

    AB - The increased risk for cardiovascular events in aging cancer survivors and those undergoing certain chemotherapeutic treatments has raised concern for more rigorous screening and surveillance methods above that of the general population. At this time, there are limited guidelines for how to best manage this vulnerable cohort. Questions regarding timing of screening, choice of imaging modality and risk reduction strategies—especially in those patients with known atherosclerotic disease—remain to be elucidated. Over a decade of case series, retrospective studies and clinical trials have shed light on the evolving role of cardiac computed tomography (CT) in this population, of which there is a relative paucity of data regarding its potential utility in the specific cardio-oncology population. Focusing on ability of cardiac CT to evaluate multiple cardiac and vascular structures, provide diagnostic and prognostic information, as well as assist interventional and surgical colleagues in surgical/percutaneous valve replacement and revascularization strategies is the premise for this review.

    KW - Cardiac computed tomography angiography

    KW - Cardiotoxicity

    KW - Coronary artery calcium score

    KW - Radiation-induced valvulopathy

    KW - Vasculotoxicity

    UR - http://www.scopus.com/inward/record.url?scp=85065410028&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85065410028&partnerID=8YFLogxK

    U2 - 10.1007/s11864-019-0645-2

    DO - 10.1007/s11864-019-0645-2

    M3 - Review article

    VL - 20

    JO - Current Treatment Options in Oncology

    JF - Current Treatment Options in Oncology

    SN - 1527-2729

    IS - 6

    M1 - 47

    ER -